A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

Liang Peng,Yan-Ping Mao,Cheng-Long Huang,Rui Guo,Jun Ma,Wei-Ping Wen,Ling-Long Tang
DOI: https://doi.org/10.3389/fonc.2020.551255
IF: 4.7
2020-09-25
Frontiers in Oncology
Abstract:OBJECTIVES: To develop a model that can predict the risk of hypothyroidism (HT) after intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC), and to accordingly recommend dose constraints.MATERIALS AND METHODS: NPC patients treated between 2011 and 2015 were retrospectively reviewed. HT was defined by an abnormally high level of thyrotropin. The dosimetry parameters V<sub>x</sub> (percentage of thyroid volume receiving more than x Gy of radiation) and V<sub>a,b</sub> (percentage of thyroid volume receiving &gt;a Gy, while ≤b Gy radiation) were calculated. The primary endpoint was the development of HT within the first 2 years after IMRT. The least absolute shrinkage and selection operator and multivariate logistic regression were used to identify predictors of HT.RESULTS: A total of 545 patients were included in the analyses, with a median follow-up of 36 months. Of the 545 patients, 138 developed HT within 2 years, and the 2-year incidence of HT was 25.3%. In patients with thyroid volume &gt;20 cm<sup>3</sup>, the 2-year incidence of HT was 11.7% (16/137); in patients with thyroid volume ≤20 cm<sup>3</sup> and V<sub>30</sub>,<sub>60</sub> ≤ 80%, the 2-year HT incidence was 19.9% (33/166); in patients with thyroid volume ≤20 cm<sup>3</sup> and V<sub>30</sub>,<sub>60</sub> &gt; 80%, the 2-year incidence of HT was 36.8% (89/242).CONCLUSION: Thyroid volume and V<sub>30</sub>,<sub>60</sub> could be reliable predictors of HT after IMRT for NPC. For patients with thyroid volume ≤20 cm<sup>3</sup>, thyroid V<sub>30</sub>,<sub>60</sub> ≤ 80% might be a useful dose constraint to adopt during IMRT planning.
oncology
What problem does this paper attempt to address?